Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants

BACKGROUND AND AIMS: ROTAVAC® (frozen formulation stored at −20 °C) and ROTAVAC 5D® (liquid formulation stable at 2–8 °C) are rotavirus vaccines derived from the 116E human neonatal rotavirus strain, developed and licensed in India. This study evaluated and compared the safety and immunogenicity of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Main Authors: Chilengi, R., Mwila- Kazimbaya, K., Chirwa, M., Sukwa, N., Chipeta, C., Velu, R.M., Katanekwa, N., Babji, S., Kang, G., McNeal, M.M., Meyer, N., Gompana, G., Hazra, S., Tang, Y., Flores, J., Bhat, N., Rathi, N.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Science 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204902/
https://ncbi.nlm.nih.gov/pubmed/33992437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2021.04.060
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares